Independent minds. Global perspective. A publication for the builders
Biotechnology / San Francisco

Alexander Haddad.

Founder
Kopra Bio

Alexander Haddad co-founded Kopra Bio, which develops viral-immunotherapy approaches for cancer research. His public biography describes neurosurgical and neuro-oncology work. The company uses engineered viruses to influence immune responses, with an initial development focus on glioblastoma and other difficult cancer-treatment settings.

Public-source researchLast checked 1 source ↘
THE STORY, IN CONTEXT

Alexander Haddad and the story of Kopra Bio.

Kopra Bio's public launch connects its platform with technology developed in a university research setting. The team combines biotechnology entrepreneurship with clinical-research experience and reports results from preclinical models. Those findings are presented by the company, not as established human treatment outcomes. The supplied material supports a development-stage company overview without independently validating safety, clinical efficacy, or comparisons with approved therapies.

FROM THE PUBLIC RECORD

Public advice & further reading.

No personal advice is attributed in this profile: a verifiable public advice source has not yet been established. The company and activity facts above remain separately sourced.

Suggest a first-person interview or essay ↗
EVIDENCE IN PLAIN SIGHT

Sources & attribution.

  1. 01
    Kopra Bio — Y Combinator company and active founder profile

    Public active-founder biography, current company status and description, and founding-team launch accounts. Company or team statements are attributed accounts, not independently audited performance results.

    www.ycombinator.com
About this profile

Independently researched from the public sources above. Featured people and companies are not affiliated with BusinessBlogz. Source dates and attribution provide context for the information shown; business claims remain attributed to their original source. Role and company details can change after review. The initials graphic is editorial artwork, not a photograph.

Request a correction or update ↗
KEEP EXPLORING

More builders in Biotechnology.

Explore the sector ↗